AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PRICE, J. M.
Right arrow Articles by MUELLER, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PRICE, J. M.
Right arrow Articles by MUELLER, L. M.
Agricola
Right arrow Articles by PRICE, J. M.
Right arrow Articles by MUELLER, L. M.

American Journal of Clinical Nutrition, Vol 20, 452-456, Copyright © 1967 by The American Society for Clinical Nutrition, Inc.

Tryptophan Metabolism in Women Using Steroid Hormones for Ovulation Control

J. M. PRICE M.D., PH.D.1, MADELINE J. THORNTON M.D.1, and LOIS M. MUELLER 1

1 From Division of Clinical Oncology and Department of Gynecology and Obstetrics, University of Wisconsin Medical School, Madison, Wisconsin 53706

Ten women using steroid hormones for ovulation control were studied for urinary excretion levels of tryptophan metabolites before and after the ingestion of a 2-g loading dose of tryptophan. The subjects took 2.5 mg of norethynodrel and 0.1 mg of mestranol (Enovid-E) daily from the 5th through the 24th day of the menstrual cycle. After the initial study, the subjects were given 25 mg of pyridoxine hydrochloride four times daily during the 48 hr required to repeat the tryptophan loading test. Basal excretion levels (before tryptophan loading) of urinary tryptophan metabolites were normal, but after the loading dose of the amino acid the pattern of tryptophan metabolites was very abnormal as compared with that of the 18 female controls. The mean excretion level for xanthurenic acid after tryptophan loading was 697 µmoles for the subjects ingesting Enovid-E compared with about 30 µmoles for the controls. The other metabolites that were excreted in increased amounts were, in order of decreasing quantities, 3-hydroxykynurenine, kynurenine, kynurenic acid, and acetylkynurenine. Pyridoxine supplementation almost completely corrected the metabolic disorder.

These results appear to demonstrate another metabolic interrelationship between steroid hormones and pyridoxine. The widespread use of steroid hormones for ovulation regulation should be considered in human metabolic studies with females, especially if pyridoxine-requiring enzyme systems are involved.




This article has been cited by other articles:


Home page
 Am. J. Clin. Nutr.Home page
M. S. Morris, M. F. Picciano, P. F Jacques, and J. Selhub
Plasma pyridoxal 5'-phosphate in the US population: the National Health and Nutrition Examination Survey, 2003-2004
Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1446 - 1454.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
A. Frazer, G. N. Pandey, and J. Mendels
Metabolism of Tryptophan in Depressive Disease
Arch Gen Psychiatry, October 1, 1973; 29(4): 528 - 535.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1967 by The American Society for Nutrition